High-Impact Markets Target expansion in low-resource regions with large cervical cancer screening needs, such as the Democratic Republic of Congo, leveraging MobileODT's portable, smartphone-based cervical cancer screening solution and remote expert consulting to drive adoption.

Affordability Advantage Position the EVA and ThermoGlide technologies as cost-effective, scalable options that reduce dependence on expensive imaging systems, appealing to public health programs, NGOs, and government-funded screening initiatives seeking rapid uptake.

AI-Enhanced Workflow Highlight AI-enabled VisualCheck capabilities to streamline screening programs, improve diagnostic consistency, and integrate with existing electronic health records and cloud platforms for end-to-end case management.

Strategic Partnerships Pursue collaborations with healthcare providers, government health ministries, and regional distributors to accelerate large-scale pilots and national screening rollouts, mirroring recent Cingulate partnership and DR Congo initiative.

Multi-Product Expansion Leverage a roadmap that includes cervical screening, thermocoagulation therapy, and image-based diagnostics to cross-sell to health systems, enabling broader adoption across cancer prevention and other biomedical imaging needs.